BIOELECTRICAL-IMPEDANCE ANALYSIS AS AN ASSESSMENT OF DIURESIS IN CONGESTIVE-HEART-FAILURE

Citation
El. Coodley et al., BIOELECTRICAL-IMPEDANCE ANALYSIS AS AN ASSESSMENT OF DIURESIS IN CONGESTIVE-HEART-FAILURE, The Annals of pharmacotherapy, 29(11), 1995, pp. 1091-1095
Citations number
23
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
10600280
Volume
29
Issue
11
Year of publication
1995
Pages
1091 - 1095
Database
ISI
SICI code
1060-0280(1995)29:11<1091:BAAAAO>2.0.ZU;2-O
Abstract
OBJECTIVE: TO compare changes in bioimpedance parameters and calculate d total body water (TBW) with conventional measurements used to assess the efficacy of diuretic therapy in the treatment of heart failure. S ETTING: A Veterans Affairs tertiary care, teaching hospital. SUBJECTS: Twelve patients with New York Heart Association (NYHA) class III cong estive heart failure (CHF). DESIGN: Prospective, consecutive sample, c ohort, open label. INTERVENTIONS: Parenterally administered furosemide ; clinically dictated, outcome-oriented, adjunctive therapy of CHF. OU TCOMES: Bioelectrical impedance analysis (BIA) parameters, measured vo lume of diuresis and changes in body weight, defined clinical endpoint s (NYHA criteria). RESULTS: Three days of diuretic therapy with furose mide (oral and/or intravenous) for CHF was associated with a measured weight loss of 4.1 +/- 0.6 kg and statistically significant increases in resistance and reactance of 20.8% +/- 2.7% and 22.7% +/- 6.1%, resp ectively (p < 0.005). Calculated TBW using BIA parameters and standard equations decreased on average by 6.1 +/- 0.6 L or 11.2% +/- 1.1% (p < 0.001). A significant inverse correlation was observed between chang e in measured body weight and total body reactance (p = 0.02). CONCLUS IONS: Single-frequency BIA appears to have limited clinical usefulness as a method of assessing diuretic therapy in the management of CHF. I ts greatest usefulness appears to lie in the assessment of serial chan ges in individual patients and patient populations that are physiologi cally or metabolically homogeneous. Further studies are needed to esta blish the validity of BIA in patients with decompensated CHF.